Join us to help stop serious infection.

Decades into a struggle to identify and treat life-threatening infections, we’ve been left with sicker patients, invincible microbes, and no new antibiotics to treat them. Our mission is to find faster, cheaper, and more precise ways to identify and treat these microbes. With more than 50 years in the field, we’ve used our combined experience to develop a novel approach that does just that.

3iDx provides technology that enables physicians to identify infectious microbes in less than 30 minutes while leaving them intact for further testing. Physicians can then prescribe the right life-saving medications quickly, which reduces the cost of care and prevents the overprescribing that hastens the spread of drug-resistant bacteria.


Our ultimate goal is to be able to provide physicians and clinical researchers with detailed information on all strains of microbes that can be found in human blood, sputum, and other bodily fluids. In doing so, we’ll do our part to save the human race from the apocalyptic threat of drug-resistant microbes. 

Our Leadership


Jim Janicki, 
President & CEO

Jim Janicki is a global executive business leader with a long track record of successful leadership at midsize and Fortune 500 companies in complex and highly regulated industries. Before joining 3i Diagnostics, Jim served as COO of another technology start-up and he has served as a corporate officer of a global diagnostic company, as well as the VP/GM of multiple global diagnostic companies. Jim earned a bachelor’s degree in chemical engineering from The Pennsylvania State University and an MBA from Western Michigan University. He is a registered professional engineer and he is on the Industrial and Professional Advisory Council to the College of Engineering at The Pennsylvania State University. He holds three technology patents


Rajesh Krishnamurthy,
Chief Technology Officer

Rajesh Krishnamurthy founded 3i Diagnostics in February 2013. He draws upon his extensive background in pharmaceutical sciences and engineering to guide 3i Diagnostics in developing breakthrough technologies for real-time detection of bacteria. Rajesh previously held director positions with Zyngenia and ImmunoGen, and spent seven years in a leadership role at Human Genome Sciences. He holds a bachelor’s degree in chemical engineering from Birla Institute of Technology and Science, and earned master’s and Ph.D. degrees in chemical and biochemical engineering from University of Maryland, Baltimore County.



3iDx collaborates with individuals from leading universities.